FTC Blesses GTCR's $675M Purchase Of Sterigenics

Law360, New York (March 8, 2011, 3:40 PM EST) -- The Federal Trade Commission on Tuesday granted an early termination of its antitrust review of Chicago private equity firm GTCR LLC's plan to buy Silverfleet Capital's medical device and pharmaceuticals sterilization company Sterigenics International Inc. for $675 million.

The FTC said it had accepted the companies' request for an early termination, meaning the agency has completed its antitrust review of the deal and decided not to take any enforcement action during the deal's statutory waiting period.

With no public shareholders in the picture, the FTC's move likely...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.